Skip to content
value.today

Pharmajet, Inc.

🇺🇸 Golden, Colorado, USAHealth CareFounded 2005
Total raised
$48 M
11 rounds on record
Latest round
$2 M
Jan 2019
First round on record
Oct 2009
Today
Private
No later event on record

Funding rounds

11 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pharmajet, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2019$2 MNo. 11Under $2 million

Pharmajet, Inc.: Raise no. 11, Jan 2019

Investors in this round

31 investors had bought by the notice of Jan 23, 2019: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • Jeffrey Jordan · Executive Officer
  • Ronald Lowy · Executive Officer, Director
  • Cody Smith · Director
  • John (Spike) Buckley · Director
  • Kim Duncan · Director
  • Markus Pedriks · Director
  • Paul Marcaccio · Director
  • Rodney Smith · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Jordan, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 23, 2019. Read the notice at the SEC.

equitySEC
Jun 2017$7 MNo. 10$2 to $10 million

Pharmajet, Inc.: Raise no. 10, Jun 2017

Investors in this round

67 investors had bought by the notice of Apr 23, 2018: 67 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • Jeffrey Jordan · Executive Officer
  • Ronald Lowy · Executive Officer, Director
  • Cody Smith · Director
  • John (Spike) Buckley · Director
  • Kim Duncan · Director
  • Markus Pedriks · Director
  • Paul Marcaccio · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Jordan, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 23, 2018. Read the notice at the SEC.

equitySEC
Jun 2015$4 MNo. 9$2 to $10 million

Pharmajet, Inc.: Raise no. 9, Jun 2015

Investors in this round

41 investors had bought by the notice of Jun 5, 2015: 41 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
$50,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$5,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • Jeffrey Jordan · Executive Officer
  • Ronald Lowy · Executive Officer, Director
  • John (Spike) Buckley · Director
  • Kim Duncan · Director
  • Markus Pedriks · Director
  • Paul Marcaccio · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Jordan, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 5, 2015. Read the notice at the SEC.

debt, optionsSEC
Jun 2015$6 MNo. 8$2 to $10 million

Pharmajet, Inc.: Raise no. 8, Jun 2015

Investors in this round

55 investors had bought by the notice of Jan 22, 2016: 55 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $7 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$12,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • Jeffrey Jordan · Executive Officer
  • Ronald Lowy · Executive Officer, Director
  • John (Spike) Buckley · Director
  • Kim Duncan · Director
  • Markus Pedriks · Director
  • Mischa Kowall · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Jordan, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 22, 2016. Read the notice at the SEC.

equity, debt, optionsSEC
Jun 2013$5 MNo. 7$2 to $10 million

Pharmajet, Inc.: Raise no. 7, Jun 2013

Investors in this round

28 investors had bought by the notice of Jul 2, 2013: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $8 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • James Bowman · Executive Officer, Director
  • Jeffrey Jordan · Executive Officer
  • John Buckley · Director
  • Kim Duncan · Director
  • Markus Pedriks · Director
  • Ronald Lowy · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Jordan, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 2, 2013. Read the notice at the SEC.

equitySEC
Mar 2013$3 MNo. 6$2 to $10 million

Pharmajet, Inc.: Raise no. 6, Mar 2013

Investors in this round

27 investors had bought by the notice of Apr 12, 2013: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • James Bowman · Executive Officer, Director
  • Jeffrey A. Jordan · Executive Officer
  • Ronald Lowy · Executive Officer, Director
  • John Buckley · Director
  • Kim Duncan · Director
  • Markus Pedriks · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James Bowman, President. Source: SEC Form D, newest notice filed Apr 12, 2013. Read the notice at the SEC.

debt, optionsSEC
Oct 2012$2 MNo. 5$2 to $10 million

Pharmajet, Inc.: Raise no. 5, Oct 2012

Investors in this round

29 investors had bought by the notice of Feb 8, 2013: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • James Bowman · Executive Officer, Director
  • Jeffrey Jordan · Executive Officer
  • John Buckley · Director
  • Kim Duncan · Director
  • Marcus Pedriks · Director
  • Ronald Lowy · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Jordan, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 8, 2013. Read the notice at the SEC.

equitySEC
Apr 2012$3 MNo. 4$2 to $10 million

Pharmajet, Inc.: Raise no. 4, Apr 2012

Investors in this round

16 investors had bought by the notice of Aug 23, 2012: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • James Bowman · Executive Officer, Director
  • Jeff Jordan · Executive Officer
  • John Buckley · Director
  • Kim Duncan · Director
  • Marcus Pedriks · Director
  • Ronald Lowy · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeff Jordan, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 23, 2012. Read the notice at the SEC.

equitySEC
Nov 2011$3 MNo. 3$2 to $10 million

Pharmajet, Inc.: Raise no. 3, Nov 2011

Investors in this round

8 investors had bought by the notice of Nov 23, 2011: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • James Bowman · Executive Officer, Director
  • Maureen Cullum · Executive Officer
  • Kim Duncan · Director
  • Markus Pedriks · Director
  • Ronald Lowy · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Maureen Cullum, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 23, 2011. Read the notice at the SEC.

equitySEC
Mar 2011$4 MNo. 2$2 to $10 million

Pharmajet, Inc.: Raise no. 2, Mar 2011

Investors in this round

17 investors had bought by the notice of Mar 23, 2011: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • James Bowman · Executive Officer, Director
  • Maureen Cullum · Executive Officer
  • Kim Duncan · Director
  • Markus Pedriks · Director
  • Tony Allard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Maureen Cullum, Cfo. Source: SEC Form D, newest notice filed Mar 23, 2011. Read the notice at the SEC.

equity, optionsSEC
Oct 2009$9 MNo. 1$2 to $10 million

Pharmajet, Inc.: Raise no. 1, Oct 2009

Investors in this round

30 investors had bought by the notice of Mar 30, 2010: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $10 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Heather Potters · Executive Officer, Director
  • Kathy Callender · Executive Officer
  • Maureen Cullum · Executive Officer
  • Rajen Dalal · Executive Officer, Director
  • Gary Calmenson · Director
  • Linda Sonntag · Director
  • Markus Pedricks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Maureen Cullum, Acting C.F.O.. Source: SEC Form D, newest notice filed Mar 30, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pharmajet, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2019).

    SEC Form D · Jan 2019

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2019

That is all the official record says: Pharmajet, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pharmajet, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 11 rounds above had up to 67 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pharmajet, Inc.
NameRoleNamed in
Heather PottersExecutive officerJan 2019
Jeffrey JordanExecutive officerJan 2019
Ronald LowyExecutive officerJan 2019
James BowmanExecutive officerJul 2013
Jeffrey A. JordanExecutive officerApr 2013
Jeff JordanExecutive officerAug 2012
Maureen CullumExecutive officerNov 2011
Kathy CallenderExecutive officerMar 2010
Rajen DalalExecutive officerMar 2010
Cody SmithDirectorJan 2019
Heather PottersDirectorJan 2019
John (Spike) BuckleyDirectorJan 2019
Kim DuncanDirectorJan 2019
Markus PedriksDirectorJan 2019
Paul MarcaccioDirectorJan 2019
Rodney SmithDirectorJan 2019
Ronald LowyDirectorJan 2019
Tony AllardDirectorJan 2019
Mischa KowallDirectorJan 2016
James BowmanDirectorJul 2013
John BuckleyDirectorJul 2013
Marcus PedriksDirectorFeb 2013
Gary CalmensonDirectorMar 2010
Linda SonntagDirectorMar 2010
Markus PedricksDirectorMar 2010
Rajen DalalDirectorMar 2010